Aug 16, 2021
In July, the World Health
Organization released its updated classification of Tumors of the
Central Nervous System. The last update was in 2016. The update
reflects the increasing role of molecular biomarkers in tumor
characterization -- a change that has major implications for how we
diagnose and treat patients with brain and spinal cord
tumors.
Joining us today to help us
understand these changes is Dr. Lynne Taylor. Dr. Taylor is a
professor of Neurology and Oncology at the University of Washington
and co-director of the Alvord Brain Tumor Center at University of
Washington Medical Center. Dr. Taylor was interviewed by ANA
Investigates producer and neuro-oncologist, Dr. Doug Ney. Series 2,
Episode #10